(Q44237440)

1 December 2017

title

Cabergoline prevents necrotic neuronal death in an in vitro model of oxidative stress (English)

1 reference

1 December 2017

Grazia Lombardi

1

1 reference

1 December 2017

Federica Varsaldi

2

1 reference

1 December 2017

Gianluca Miglio

3

1 reference

1 December 2017

Maria Grazia Papini

4

1 reference

1 December 2017

Angelo Battaglia

5

1 reference

1 December 2017

Pier Luigi Canonico

6

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

European Journal of Pharmacology

1 December 2017

published in

1 reference

1 December 2017

volume

457

1 reference

1 December 2017

issue

2-3

1 reference

1 December 2017

page(s)

95-98

1 reference

In the neuronal cell line SH-SY5Y, oxidative stress-induced free radical overproduction causes cell death without any participation of intracellular Ca(2+) increase.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

Efficacy of cabergoline in long-term use: results of three observational studies in 1,500 patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

Pharmacodynamic and Pharmacokinetic Features of Cabergoline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

Reduction of lipid peroxidation in different rat brain areas after cabergoline treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

Free radical scavengers: chemical concepts and clinical relevance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

Excitatory amino acids as a final common pathway for neurologic disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

Recent advances in the genetics and pathogenesis of Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

Effects of acute or prolonged administration of cabergoline on parkinsonism induced by MPTP in common marmosets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

Pergolide protects SH-SY5Y cells against neurodegeneration induced by H(2)O(2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

Molecular pharmacology of vitamin E: structural aspects of antioxidant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

The dopamine agonist cabergoline provides neuroprotection by activation of the glutathione system and scavenging free radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902683-3

10.1016/S0014-2999(02)02683-3

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference